Table 1 Characteristics of patients treated at the HCT unit
Characteristic | 2018 | 2019 |
|---|---|---|
No. of pat. for allogeneic transplantation | 162 | 158 |
Age | ||
Median (range), years | 58 (19–75) | 59 (19–74) |
Sex | ||
Male, n (%) | 106 (65) | 90 (57) |
Female, n (%) | 56 (35) | 68 (43) |
Conditioning regimen | ||
Myeloablative conditioning, n (%) | 59 (36) | 60 (38) |
Reduced intensity conditioning, n (%) | 71 (44) | 68 (43) |
Sequential conditioning, n (%) | 32 (20) | 30 (19) |
Status at start of cond | ||
Complete remission, n (%) | 66 (41) | 60 (38) |
Active disease, n (%) | 96 (59) | 98 (62) |
Diseases | ||
Acute myeloid leukemia, n (%) | 85 (53) | 80 (51) |
Acute lymphoblastic leukemia, n (%) | 15 (9) | 12 (8) |
Myelodysplastic syndrome, n (%) | 24 (15) | 18 (11) |
Myeloproliferative neoplasia, n (%) | 12 (7) | 22 (14) |
Lymphoma, n (%) | 24 (15) | 19 (12) |
Multiple myeloma, n (%) | 2 (1) | 5 (3) |
Aplastic anemia, n (%) | 0 (0) | 2 (1) |
Duration of neutropenia after transplant | ||
Median (range), days | 16 (4–56) | 16 (0–56) |
Duration of hospitalization after transplant | ||
Median (range), days | 30 (10–155) | 30 (6–178) |
Patients with readmissions after transplant | ||
Total, n | 23 | 18 |
Infections, n | 7 | 1 |
Graft-versus-host disease, n | 12 | 9 |
Other, n | 4a | 8b |